Back to results
US 2025/0152545 A1Published application
Novel antiviral compositions comprising oleic acid
AssigneeSubintro Limited
InventorsWilliam Garth RAPEPORT, Kazuhiro ITO, Jagdeep SHUR
Life of this patent
Estimating the term…
Loading patent…
Loading patent…
AssigneeSubintro Limited
InventorsWilliam Garth RAPEPORT, Kazuhiro ITO, Jagdeep SHUR
Estimating the term…
The invention provides inter alia a liquid pharmaceutical formulation suitable for topical administration to the lung or nose comprising a surfactant component selected from the group consisting of oleic acid or a pharmaceutically acceptable salt thereof and mixtures of oleic acid or a pharmaceutically acceptable salt thereof with polyoxyethylene sorbitan fatty acid esters optionally together with an anti-viral agent for use in the treatment or prevention of viral infection or disease associated with viral infection as a medicament for administration topically to the lung or nose.
A liquid pharmaceutical formulation suitable for topical administration to the lung or nose comprising (i) a surfactant component selected from the group consisting of oleic acid or a pharmaceutically acceptable salt thereof and mixtures of oleic acid or a pharmaceutically acceptable salt thereof with polyoxyethylene sorbitan fatty acid esters and (ii) an anti-viral agent.
5-22. (canceled)
(canceled)
26-37. (canceled)
40-49. (canceled)
A method of treating or preventing viral infection or disease associated with viral infection which comprises administering to a subject in need thereof topically to the lung or nose a therapeutically or prophylactically effective amount of a pharmaceutical formulation comprising a surfactant component selected from the group consisting of oleic acid and mixtures of oleic acid with polyoxyethylene sorbitan fatty acid esters.
52-55. (canceled)
A liquid pharmaceutical formulation suitable for topical administration to the lung or nose comprising a surfactant component selected from the group consisting of oleic acid or a pharmaceutically acceptable salt thereof and mixtures of oleic acid or a pharmaceutically acceptable salt thereof with polyoxyethylene sorbitan fatty acid esters.
Dependencies are inferred from the claim text.